Remaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy
Clinical trial NCT05789797 · COMPLETED
Trial details
- NCT number
- NCT05789797
- Sponsor
- POLYSAN Scientific & Technological Pharmaceutical Company
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-12
- Primary completion
- 2024-11-01
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.